Category Archives: World Congress for Hair Research

10th World Congress for Hair Research

The usually biennial World Congress for Hair Research is the most important conference in the world when it comes to hair loss related research. While some of the presentations at this conference always cover existing treatments (such as finasteride, hair transplants and wigs), the majority cover more futuristic technologies and research. Some presentations also entail entirely new takes upon existing technologies and research.

10th World Congress for Hair Research

Previously I covered both the 8th World Congress for Hair Research in 2014 and the 9th World Congress for Hair Research in 2015. For some reason, there was no conference in 2016. However, the 10th World Congress for Hair Research is scheduled to take place in Kyoto, Japan from October 31st 2017 through November 3rd 2017.

Moreover, just as in 2015, “Hellouser” is attending the conference and has e-mailed me that he will be posting his videos on YouTube, but still needs to raise some more funds. You can donate towards his trip here. He is regularly posting updates in this thread on HLT.

Key Presentations of Interest

As is always the case at this Congress, a who’s who of the hair loss research world is presenting. Asia based researchers are especially well represented this time around. Readers can go through the oral presentation list and see which items interest them the most. Poster presentation list is here (link no longer working).

It is hard to try to compile a list of just 10 or so items of interest as I have done in the past, since around one-third of the presentations look highly interesting. Some initial thoughts:

  • While it seems like locally based Dr. Takashi Tsuji from RIKEN is not presenting in person, another researcher (Dr. Koh-ei Toyoshima) who collaborates with Dr. Tsuji is presenting: “Basic study to clinical phase, a fully functional organ regenerative therapy for the hair follicle”.
  • Also from RIKEN, Dr. Hironobu Fujiwara will discuss “Reciprocal interactions between epidermal stem cells and their environment”.
  • The other renowned locally headquartered entity of interest, Shiseido, is very much present. Several of the company’s researchers are participating, including the respected Dr. Jiro Kishimoto.
  • Dr. Mayumi Ito will discuss something that all of us have discussed on here a lot lately: “Wound healing and hair follicle regeneration”.
  • Dr. George Cotsarelis discusses prostaglandins.
  • Dr. Bessam Farjo is one of many keynote speakers, and his lecture is titled: “A new approach to hair cell therapy: Combining medical and scientific innovation in hair ‘cloning'”.
  • Most of the topics in the “Stem Cells and the Niche” and “Tissue Engineering using Hair Follicle Cells” sections are of major relevance to this blog’s subject matter. Six of the ten presentations in these two sections are by Japanese researchers (!); three are by Korean researchers (!); and one by Germany’s Dr. Gerd Lindner who seemed to have disappeared in recent years. His presentation is titled “Bioengineering human hair follicle anlagen within a full thickness skin equivalent”.
  • Dr. Antonella Tosti has an interesting presentation titled: “A new topical WNT/beta-catenin activator in the treatment of men with male pattern hair loss”. What could that topical be?
  • A significant number of presentations concern natural products (aloe, botanicals, ginseng, green tea, Korean native plants), lasers and PRP. All these treatments are somewhat controversial, at least insofar as regrowing hair on totally bald regions of the scalp goes.
  • “Alopecia areata” and “female hair loss” are both well covered subjects, especially the former.
  • Surprisingly, while more than five presentations cover Finasteride, none covers Dutasteride, even though the latter is approved as a hair loss treatment in Japan and South Korea.

Updates from the 2015 WCHR and Related News

The 9th World Congress for Hair Research just ended in Miami and there is a surprising lack of online publicly available information regarding key developments. Some companies often publish their presentations on their websites several days after the end of such conferences, so I will update this post in the next week as new information comes out.

2015 Word Congress for Hair Research (WCHR) Updates

Update: 9th World Conference for Hair Research abstracts now available online.

Update: Below is the unbelievable before and after image from Histogen’s Dr. Gail Naughton’s presentation that everyone is talking about (Edit: Image was later removed from source site).

Update: Hellouser’s Youtube channel.

Update: Spencer Kobren’s interview with Histogen’s Dr. Gail Naughton, including all her slides. Very encouraging and an absolute must see.

Update: Spencer Kobren’s interview with Replicel’s Lee Buckler.

— The best place to get updates remains Hellouser’s thread on the HLT forums. He is apparently back in Canada and fatigued at present, but will slowly update that thread (or perhaps create new threads on different companies in that portion of the HLT forums). He is going to load his audio files somewhere outside the forums too.

Samumed came out yet another press release today, summarizing its presentation at the Miami Congress. I am getting more optimistic about the company’s unique SM04554 topical product that tackles hair loss via the Wnt pathway. At present, the company has only concluded that the product is very safe based on its recently completed 300 person trial (interestingly, one of the co-organizers of the 2015 WCHR, Dr. WIlma Bergfeld, was involved in this trial via the Cleveland center).

Actual data on new hair growth will come out as it becomes available, which I am hoping will be in early 2016. The conclusion of the press release is encouraging, even if not pertaining to humans: “SM04554 has been shown to generate new hair follicles and increase hair count in multiple animal models.” At the same time, we have to be wary from past experiences that all these press releases could very well be just a means to attract publicity and funding. The final product could at best always end up being no better than Rogaine.

— I am disappointed that the 2015 WCHR Twitter account has been completely silent during and after the Congress. It is unlikely that they will publish anything this week either, but maybe it is still worth keeping an eye on that account before it ends in Twitter purgatory. Maybe “Helllouser” should get the wwww.twitter.com/2016WCHR account now while no-one has it and then tell the Japanese organizers of next year’s Congress that he will do a much better job of updating it?

— I discussed Allergan twice in this blog recently (see here and here) and it seems like the company is now definitely merging with Pfizer. Together, the new entity will be by far the world’s largest pharmaceutical company. Too early to tell how if at all this will impact the release of Allergan’s Bimatoprost and Setipiprant drugs to treat hair loss.

— Replicel usually publishes its latest presentation on its website and announces them via its Twitter account.

— Histogen remains the big mystery. A few months ago, most people had given up on it. Then things changed and I wrote this post. Now “Hellouser” is saying that he was very impressed with their presentation. I am really looking forward to his interview with CEO Gail Naughton.